54 000 TB deaths in SA in 2024, according to WHO
Around 54 000 people died of TB in South Africa in 2024 and 249 000 fell ill with the disease, according to new estimates from the World Health Organization. Marcus Low reports.
SA and Indonesia team up on massive asymptomatic TB study
Over the last decade, there’s been growing evidence that people can have TB without having any symptoms. But there is still much uncertainty over how such asymptomatic TB functions in the body and how infectious it is. An ambitious study, set to be conducted in South Africa and Indonesia, is trying to find some answers. Elri Voigt reports.
WHO recommends nutritional support in fight against TB – government claims to take it on board
Evidence has been mounting that poor nutrition impacts both someone’s risk of falling ill with TB and how well they do once ill. But as the World Health Organization (WHO) releases new guidelines on TB and nutrition, it is unclear to what extent the South African government is ready to invest in providing people with nutritional support as part of the fight against TB. Biénne Huisman reports.
Francois Venter | Slow motion denialism: Our leaders are allowing the HIV response to collapse
South Africa is staging a sequel to Mbeki-era denialism, only this time, the science, solutions, and costs are clearer, argues Professor Francois Venter.
#InTheSpotlight | TB’s tight grip: Why this curable disease is so hard to treat
TB can be cured, but ridding the body of the bug often takes many months and usually requires taking four or more different medicines. In this Spotlight special briefing, Elri Voigt zooms in on what makes the TB bacterium so hard to beat.
Large numbers of TB survivors in SA struggling with lung damage, experts say
There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.
Francois Venter | Our HIV programme is collapsing — and our government is nowhere to be seen
We’re watching the largest HIV treatment programme in the world unravelling in real time. We don’t need perfection, but we do need a combination of urgency, action, and strategy to save it, argues Professor Francois Venter.
Inside the SAMRC’s race to rescue health research in SA
Health research in South Africa has been plunged into crisis with the abrupt termination of several large research grants from the US, with more grant terminations expected in the coming days and weeks. Professor Ntobeko Ntusi, head of the South African Medical Research Council, tells Spotlight about efforts to find alternative funding and to preserve the country’s health research capacity.
Tongue swabs – Where might these experimental TB tests eventually fit in?
While likely years away from widespread use, a test for TB that relies on a simple tongue swab instead of a person having to cough up sputum is showing promise. Elri Voigt takes stock of how the test works and asks experts what its future role might be.
New research challenges thinking on the places where TB is transmitted
For centuries, it was believed that tuberculosis spread primarily when a vulnerable person spends hours in a poorly ventilated space with someone infectious. But new findings suggest that much TB transmission also occurs through casual contact. Biénne Huisman reports.
SA has world class medical researchers – they can and should be bailed out
The sudden and severe US cuts to grants from the world’s largest health research funder threaten to unravel the medical research landscape in South Africa. A crucial question now is whether the government will turn this crisis into an opportunity for renewal, write Marcus Low and Nathan Geffen.
High hopes for major TB vaccine study recently launched in Paarl
The world desperately needs an effective TB vaccine to reduce the illness and death still being caused by the centuries’ old bacterium. Chris Bateman visited a study site in Paarl where a promising experimental TB vaccine is now being tested as part of a large multi-country clinical trial.